These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 463998)

  • 1. Long-term course of chloroquine retinopathy after cessation of medication.
    Brinkley JR; Dubois EL; Ryan SJ
    Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chloroquine retinopathy].
    François J; de Rouck A; Cambie E; de Laey JJ
    Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Rüther K; Foerster J; Berndt S; Schroeter J
    Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine retinopathy.
    Weiner A; Sandberg MA; Gaudio AR; Kini MM; Berson EL
    Am J Ophthalmol; 1991 Nov; 112(5):528-34. PubMed ID: 1951589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular effects and safety of antimalarial agents.
    Easterbrook M
    Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
    Hart WM; Burde RM; Johnston GP; Drews RC
    Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS; Saatci OA
    Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C; Bechetoille A; Ebran JM
    J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-onset chloroquine retinopathy.
    Ehrenfeld M; Nesher R; Merin S
    Br J Ophthalmol; 1986 Apr; 70(4):281-3. PubMed ID: 3964626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy.
    Kim DG; Yoon CK; Kim HW; Lee SJ
    Can J Ophthalmol; 2018 Jun; 53(3):e103-e107. PubMed ID: 29784170
    [No Abstract]   [Full Text] [Related]  

  • 16. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
    Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
    Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular toxicity of antimalarial drugs. Long-term follow-up.
    Carr RE; Henkind P; Rothfield N; Siegel IM
    Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
    [No Abstract]   [Full Text] [Related]  

  • 18. OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.
    LLOYD LA; HILTZ JW
    Can Med Assoc J; 1965 Mar; 92(10):508-13. PubMed ID: 14275038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial drug retinopathy: A typical « Bull's eyes » appearance of fundus.
    Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
    Joint Bone Spine; 2018 May; 85(3):369. PubMed ID: 28512007
    [No Abstract]   [Full Text] [Related]  

  • 20. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
    Salu P; Uvijls A; van den Brande P; Leroy BP
    Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.